Hutchin Hill Capital’s Boston Scientific BSX Stock Holding History

Hutchin Hill Capital’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-12,300	Closed	-$341K	–	750
2017 Q2	$341K	Sell	12,300 -2,500	-17%	-$66.3K	0.01%	733
2017 Q1	$368K	Buy	+14,800	New	+$360K	0.01%	766
2015 Q3	–	Sell	-135,500	Closed	-$2.4M	–	599
2015 Q2	$2.4M	Buy	135,500 +31,300	+30%	+$559K	0.06%	286
2015 Q1	$1.85M	Buy	+104,200	New	+$1.65M	0.05%	319
2014 Q4	–	Sell	-94,500	Closed	-$1.12M	–	562
2014 Q3	$1.12M	Sell	94,500 -18,800	-17%	-$237K	0.04%	350
2014 Q2	$1.45M	Sell	113,300 -2,300	-2%	-$29.9K	0.07%	253
2014 Q1	$1.56M	Buy	+115,600	New	+$1.52M	0.08%	269

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Hutchin Hill Capital's BSX Position: Q3 2017 in Review

Hutchin Hill Capital sold out of Boston Scientific (BSX) in Q3 2017, closing a stake of 12,300 shares — an estimated $341K sold.

Hutchin Hill Capital first reported a position in BSX in Q1 2014 and held it in 7 quarters. The position peaked at $2.4M in Q2 2015. 547 funds tracked by Wall St. Rank hold BSX as of Q3 2017.

Hutchin Hill Capital reported no remaining Boston Scientific position as of Q3 2017 after selling out during the quarter.
Hutchin Hill Capital sold 12,300 Boston Scientific shares in Q3 2017, an estimated $341K.
Hutchin Hill Capital first reported a position in Boston Scientific in Q1 2014 and held it in 7 quarters.
Hutchin Hill Capital's Boston Scientific position peaked at $2.4M in Q2 2015.
547 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2017.

Based on Hutchin Hill Capital's 13F filing for Q3 2017, filed 14 Nov 2017.